Search Results
MCP 60 Seconds With Dr Andrew Badley on Lenzilumab & Severe COVID-19 Pneumonia
MCP 60 Seconds With Dr Andrew Badley on Translation to Practice
GM-CSF Neutralization With Lenzilumab in Severe COVID-19 Pneumonia
Dr. Andrew Badley, Mayo Clinic's COVID-19 Research Task Force, says this is a remarkable moment.
Dr. Andrew Badley - Will current COVID-19 treatments and therapies work against omicron?
Dr. Andrew Badley - COVID-19 oral pill gets advisory approval
Lenzilumab
6-9-21 COVID-19: In The Pipeline Therapeutics
New COVID-19 treatment shown to improve patient survival by more than 50%, studies show
Pneumonia And COVID-19: Relationship
Humanigen chosen by National Institute of Health's upcoming coronavirus clinical trial
Humanigen CEO gives update on Covid-19 treatment
